Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Teva
Accenture
US Department of Justice
QuintilesIMS
Moodys
Federal Trade Commission

Generated: July 15, 2019

DrugPatentWatch Database Preview

Patent: 10,220,047

Try a free trialSee Plans and Pricing

« Back to Dashboard

Summary for Patent: 10,220,047
Title:Adjunctive therapy with 25-hydroxyvitamin D and articles therefor
Abstract: Methods, compositions, and kits for adjunctive therapy using 25-hydroxyvitamin D are disclosed. The 25-hydroxyvitamin D may be administered with an agent that increases the risk of hypocalcemia, such as cinacalcet or a salt thereof, and/or an anticancer agent. The adjunctive therapy is effective to treat and prevent iatrogenic hypocalcemia and/or secondary hyperparathyroidism, as well as delay cancer progression and the time to a post-treatment skeletal related event.
Inventor(s): Petkovich; P. Martin (Kingston, CA), Melnick; Joel Z. (Wilmette, IL), White; Jay A. (Newmarket, CA), Tabash; Samir P. (Whitby, CA), Bishop; Charles W. (Miami Beach, FL), Peers; Susan (Toronto, CA), Strugnell; Stephen A. (Bay Harbor Islands, FL)
Assignee: OPKO IRELAND GLOBAL HOLDINGS, LTD. (Grand Cayman, KY)
Application Number:14/866,155
Patent Claims:see list of patent claims

Details for Patent 10,220,047

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source
Nps Pharms Inc NATPARA parathyroid hormone INJECTABLE;INJECTION 125511 004 2015-01-23 ➤ Sign Up OPKO IRELAND GLOBAL HOLDINGS, LTD. (Grand Cayman, KY) ➤ Sign Up RX Orphan search
Nps Pharms Inc NATPARA parathyroid hormone INJECTABLE;INJECTION 125511 003 2015-01-23 ➤ Sign Up OPKO IRELAND GLOBAL HOLDINGS, LTD. (Grand Cayman, KY) ➤ Sign Up RX Orphan search
Nps Pharms Inc NATPARA parathyroid hormone INJECTABLE;INJECTION 125511 002 2015-01-23 ➤ Sign Up OPKO IRELAND GLOBAL HOLDINGS, LTD. (Grand Cayman, KY) ➤ Sign Up RX Orphan search
Nps Pharms Inc NATPARA parathyroid hormone INJECTABLE;INJECTION 125511 001 2015-01-23 ➤ Sign Up OPKO IRELAND GLOBAL HOLDINGS, LTD. (Grand Cayman, KY) ➤ Sign Up RX Orphan search
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source

Subscribe to access the full database, or try a Free Trial

International Patent Family for US Patent 10,220,047

Country Patent Number Publication Date
World Intellectual Property Organization (WIPO) 2016020508 Feb 11, 2016
World Intellectual Property Organization (WIPO) 2016020508 Mar 31, 2016
World Intellectual Property Organization (WIPO) 2017050438 Mar 30, 2017
United States of America 2016038514 Feb 11, 2016
United States of America 2018021354 Jan 25, 2018
United States of America 2018085381 Mar 29, 2018
Country Patent Number Publication Date

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fish and Richardson
McKesson
Moodys
AstraZeneca
Merck
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.